Evidence map›Paper›PMID 36923623›Full record

ArticleNagoya journal of medical science2023

A case of eosinophilic polyangiitis with granulomatosis that evolved to cardiac arrest due to advanced atrioventricular block.

Yuichiro Sakurai, Chiyako Oshikata, Takaharu Katayama, Shunsuke Takagi, Yasushi Kaneko, Kikuo Yo, Takeshi Kaneko, Hiroyuki Kubota, Takashi Matsubara, Naomi Tsurikisawa

Open access · greenAbstract readCase Reports
In one paragraph

Article in Nagoya journal of medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yuichiro SakuraiDepartment of Allergy and Respirology, Hiratsuka City Hospital, Hiratsuka, Japan.
Chiyako OshikataDepartment of Allergy and Respirology, Hiratsuka City Hospital, Hiratsuka, Japan.
Takaharu KatayamaDepartment of Cardiology, Hiratsuka City Hospital, Hiratsuka, Japan.
Shunsuke TakagiDepartment of Cardiology, Hiratsuka City Hospital, Hiratsuka, Japan.
Yasushi KanekoDepartment of Emergency and Critical Care Medicine, Hiratsuka City Hospital, Hiratsuka, Japan.
Kikuo YoDepartment of Emergency and Critical Care Medicine, Hiratsuka City Hospital, Hiratsuka, Japan.
Takeshi KanekoDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hiroyuki KubotaDepartment of Gastroenterology, Shizuoka City Shimizu Hospital, Shizuoka, Japan.
Takashi MatsubaraDepartment of Cardiology, Hiratsuka City Hospital, Hiratsuka, Japan.
Naomi TsurikisawaDepartment of Allergy and Respirology, Hiratsuka City Hospital, Hiratsuka, Japan.
Hiratsuka City Hospital · JPYokohama City University · JPNational Hospital Organization · JPShizuoka City Shimizu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac manifestations are the major cause of mortality in patients with eosinophilic granulomatosis with polyangiitis (EGPA). Among these manifestations in EGPA patients, in the literature, there are fewer reports describing bradycardia in EGPA patients than those describing tachycardia. A 50-year-old woman with a history of childhood-onset asthma. At age 28, she was diagnosed with eosinophilic gastroenteritis without the diagnosis of EGPA and was started on a systemic steroid and had maintenance daily dose of 2.5 mg after gradually tapered. She had experiencing dizziness and palpitations 2 weeks after discontinuation of the steroid treatment. At emergency visit, electrocardiography revealed an advanced atrioventricular block of 3:1 or less. Forty-eight minutes after the start of electrocardiography, only a P wave was observed and cardiac arrest occurred for 9 s and temporary emergency pacing was performed immediately. She was diagnosed as EGPA presenting leukocyte count, 16,500/µL, 42.8% of which were eosinophils and sinusitis in computed-tomography. She could be survival by treatment of steroid, following the patient to withdraw from an external pacemaker. She received prednisolone of 60 mg, intravenous cyclophosphamide and intravenous immunoglobulin. She had relapsed presenting peripheral eosinophilia, abdominal and numbness in the toes of the left leg pain, but not arrythmia after tapered of prednisolone. Following additional steroid pulse, she had an increase of prednisolone and continued by intravenous cyclophosphamide, intravenous immunoglobulin and started mepolizumab. We presented a severe case of EGPA presenting an advanced atrioventricular block into cardiac arrest.

Indexed as

AsthmaAtrioventricular BlockChurg-Strauss SyndromeGranulomatosis with PolyangiitisHeart ArrestAdultCyclophosphamideFemaleHumansImmunoglobulins, IntravenousMiddle AgedPrednisoloneCyclophosphamideImmunoglobulins, IntravenousPrednisoloneadvanced atrioventricular blockeosinophilic gastroenteritiseosinophilic granulomatosis with polyangiitisimmunoglobulinmepolizumab

Identifiers

PMID36923623
PMCPMC10009639
OpenAlexW4327682000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.